Health Condition 1: C109- Malignant neoplasm of oropharynx,unspecified Health Condition 2: C14- Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx Health Condition 3: C140- Malignant neoplasm of pharynx, unspecified
Conditions
Interventions
Control Intervention1: not applicable: not applicable
Sponsors
Nil
Eligibility
Inclusion criteria
Inclusion criteria: 1.Adult patient (=18 years old) having histologically proven head and neck cancer and diagnosed by Oncologist. 2.Head and Neck cancer patients receiving definitive chemoradiotherapy and adjuvant chemoradiotherapy. 3.Head and Neck cancer patient in cancer Stage II to stage IVa according to AJCC TNM classification. 4.Patients who have undergone minimum 6 cycles of chemoradiotherapy in 2 months. 5.Patient’s ability to understand and follow the test procedure.
Exclusion criteria
Exclusion criteria: 1.Head and Neck cancer patients having consciousness disturbance (i.e., delirium) or being unable to communicate. 2.Patients with known distant metastases. 3.Patients with visual impairment major neurological and musculoskeletal problems limiting their test performance. 4.Patients with emotional disturbance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Montreal Cognitive Assessment Trail Making Test A&B Reys auditory verbal learning test Functional Assessment of Cancer Therapy Cognitive Function 6 min walk test Hand grip strength Gait speed Katz Index of Independence the Lawton IADL Scale Timepoint: All the outcome measures will be assessed at Baseline 6 weeks post chemoradiotherapy Followup assessment 2 months after discharge | — |
Secondary
| Measure | Time frame |
|---|---|
| fatigue assessment by NCCN scaleTimepoint: at Baseline 6 weeks post chemoradiotherapy Followup assessment 2 months after discharge | — |
Countries
India
Contacts
Public ContactDr Vijaya Kumar K
Kasturba Medical College, Mangalore, MAHE
Outcome results
None listed